Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
262.00
-4.58 (-1.72%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corp
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Recap: Insulet Q1 Earnings
May 04, 2023
Via
Benzinga
Insulet Announces New Organizational Structure to Drive Further Growth
May 04, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
May 04, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
May 02, 2023
From
Insulet Corporation
Via
Business Wire
4 Analysts Have This to Say About Insulet
April 17, 2023
Via
Benzinga
Analyst Expectations for Insulet's Future
February 24, 2023
Via
Benzinga
Preview: Insulet's Earnings
February 22, 2023
Via
Benzinga
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
April 25, 2023
From
Insulet Corporation
Via
Business Wire
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
March 30, 2023
From
Insulet Corporation
Via
Business Wire
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
February 24, 2023
From
Insulet Corporation
Via
Business Wire
2 Best Medical Device Stocks for 2023
December 08, 2022
Insulet and Conmed ought to be medtech's shining stars in 2023.
Via
The Motley Fool
Looking Into Insulet's Return On Invested Capital
November 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
Via
Benzinga
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
February 21, 2023
From
Insulet Corporation
Via
Business Wire
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade
February 14, 2023
Are these stocks still good buys today?
Via
The Motley Fool
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
February 14, 2023
From
Insulet Corporation
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Insulet to Present at Upcoming Investor Conferences
February 14, 2023
From
Insulet Corporation
Via
Business Wire
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
February 13, 2023
From
Insulet Corporation
Via
Business Wire
The 7 Best Tech Stocks to Buy for February 2023
February 09, 2023
Some of the best tech stocks are looking increasingly attractive as the worst fears fail to materialize. Here are seven to consider.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
January 26, 2023
Via
Benzinga
Insulet Has Potential To Gain More Than Analysts Are Forecasting
January 18, 2023
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range.
Via
MarketBeat
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
January 12, 2023
From
Insulet Corporation
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
December 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally
December 17, 2022
UnitedHealth is among medical stocks holding key support.
Via
Investor's Business Daily
Insulet to Present at Upcoming Investor Conferences
November 22, 2022
From
Insulet Corporation
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
November 15, 2022
Via
Benzinga
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
November 14, 2022
From
Insulet Corporation
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.